Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

05-1049 Anti-Met (extracellular) Antibody, clone 4F8.2

05-1049
100 µg  
Purchase on Sigma-Aldrich

Offres spéciales

Aperçu

Replacement Information

Offres spéciales

Tableau de caractéristiques principal

Species ReactivityKey ApplicationsHostFormatAntibody Type
HIH(P), WBMPurifiedMonoclonal Antibody
Description
Catalogue Number05-1049
Replaces05-237
DescriptionAnti-Met (extracellular) Antibody, clone 4F8.2
Alternate Names
  • HGF receptor
  • HGF/SF receptor
  • Met proto-oncogene tyrosine kinase
  • SF receptor
  • Scatter factor receptor
  • met proto-oncogene
  • met proto-oncogene (hepatocyte growth factor receptor)
  • oncogene MET
Background InformationThe proto-oncogene Met (c-Met, HGF/SF Receptor, HGFR) is a receptor tyrosine kinase that is activated upon Hepatocyte Growth Factor (HGF) binding. This stimulates the autophosphorylation on Tyr1234/Tyr1235 which leads to pleiotropic downstream signaling events in epithelial cells that stimulate multiple cellular processes including cell proliferation, growth, differentiation, cell migration/ invasion, and tumorigenesis. These effects are mediated by SH2 domain-containing proteins that bind to the C-terminal tail of c-Met. Chronic stimulation of Met on cancer cells is thought to play a role in metastasis and dysregulation of c-Met activity is directly associated with oncogenesis, making it an important cancer target.
References
Product Information
FormatPurified
PresentationPurified mouse monoclonal in 0.1M Tris-Glycine (pH7.4), 150mM NaCl with 0.05% NaN3.
Quality LevelMQ100
Applications
ApplicationDetect Met (extracellular) using this Anti-Met (extracellular) Antibody, clone 4F8.2 validated for use in IH(P) & WB.
Key Applications
  • Immunohistochemistry (Paraffin)
  • Western Blotting
Application NotesWestern Blot Analysis:
This lot detected Met at 1:1,000 dilution in HEK293 cell lysate resolved via SDS-PAGE and transferred to PVDF.

Immunohistochemistry Analysis :
Biological Information
ImmunogenGST-fusion protein corresponding to amino acids 80-434 of human Met.
EpitopeExtracelluar domain (N-term)
Clone4F8.2
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostMouse
SpecificityDetects Met on its extracellular domain.
IsotypeIgG2bκ
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThe proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq].
Gene Symbol
  • AUTS9
  • EC 2.7.10.1
  • HGFR
  • OTTHUMP00000069168
  • RCCP2
  • c-Met
Purification MethodProtein G Purified
UniProt Number
UniProt SummaryFUNCTION: Receptor for hepatocyte growth factor and scatter factor. Has a tyrosine-protein kinase activity.

Catalytic activity ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.

SUBUNIT:Heterodimer formed of an alpha chain (50 kDa) and a beta chain (145 kDa) which are disulfide linked. Binds PLXNB1 and GRB2. Interacts with SPSB1, SPSB2 and SPSB4 By similarity. Interacts with INPP5D/SHIP1. When phosphorylated at Tyr-1356, interacts with INPPL1/SHIP2. Interacts with RANBP9 and RANBP10, as well as SPSB1, SPSB2, SPSB3 and SPSB4. SPSB1 binding occurs in the presence and in the absence of HGF, however HGF treatment has a positive effect on this interaction.

LOCATION: Single-pass type I membrane protein.

DOMAIN:The kinase domain is involved in SPSB1 binding.

DISEASE: Activation of MET after rearrangement with the TPR gene produces an oncogenic protein.

Defects in MET may be associated with gastric cancer.

Defects in MET are a cause of hepatocellular carcinoma (HCC) [MIM:114550].

Defects in MET are a cause of hereditary papillary renal carcinoma (HPRC) [MIM:605074]; also known as papillary renal cell carcinoma 2 (RCCP2). HPRC is a form of inherited kidney cancer characterized by a predisposition to develop multiple, bilateral papillary renal tumors. The pattern of inheritance is consistent with autosomal dominant transmission with reduced penetrance.

Genetic variations in MET may be associated with susceptibility to autism type 1B (AUTS1B) [MIM:608636]. Autism is a neurodevelopmental disorder characterized by disturbance in language, perception and socialization. The disorder is classically defined by a triad of limited or absent verbal communication, a lack of reciprocal social interaction or responsiveness, and restricted, stereotypical, and ritualized patterns of interests and behavior.

SIMILARITIES: Belongs to the protein kinase superfamily. Tyr protein kinase family.

Contains 3 IPT/TIG domains.

Contains 1 protein kinase domain.

Contains 1 Sema domain.

Molecular Weight170 kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceRoutinely evaluated by Western Blot.

Western Blot Analysis:
This lot detected Met at 1:1,000 dilution in HEK293 cell lysate resolved via SDS-PAGE and transferred to PVDF.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
Handling Recommendations: Upon receipt, and prior to removing the cap, centrifuge the vial and gently mix the solution.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Référence GTIN
05-1049 04053252508271

Documentation

Anti-Met (extracellular) Antibody, clone 4F8.2 FDS

Titre

Fiche de données de sécurité des matériaux (FDS) 

Anti-Met (extracellular) Antibody, clone 4F8.2 Certificats d'analyse

TitreNuméro de lot
Anti-Met (extracellular), clone 4F8.2 - 2128270 2128270
Anti-Met (extracellular), clone 4F8.2 - 2433536 2433536
Anti-Met (extracellular), clone 4F8.2 - 2297318 2297318
Anti-Met (extracellular), clone 4F8.2 - 3270777 3270777
Anti-Met (extracellular), clone 4F8.2 - 4167025 4167025
Anti-Met (extracellular), clone 4F8.2 - DAM1581071 DAM1581071
Anti-Met (extracellular), clone 4F8.2 - NG1551485 NG1551485
Anti-Met (extracellular), clone 4F8.2 -2517865 2517865
Anti-Met (extracellular), clone 4F8.2 -2763989 2763989
Anti-Met (extracellular), clone 4F8.2 Monoclonal Antibody 3023594

Références bibliographiques

Aperçu de la référence bibliographiqueNº PubMed
Dissecting the role of human embryonic stem cell-derived mesenchymal cells in human umbilical vein endothelial cell network stabilization in three-dimensional environments.
Boyd, NL; Nunes, SS; Krishnan, L; Jokinen, JD; Ramakrishnan, VM; Bugg, AR; Hoying, JB
Tissue engineering. Part A  19  211-23  2013

Afficher le résumé
22971005 22971005
Cellular mechanisms underlying the regulation of dendritic development by hepatocyte growth factor.
Charles Finsterwald,Jean-Luc Martin
The European journal of neuroscience  34  2010

Afficher le résumé
21895802 21895802
Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a.
Schiering, Nikolaus, et al.
Proc. Natl. Acad. Sci. U.S.A., 100: 12654-9 (2003)  2003

14559966 14559966

Brochure

Titre
Advancing cancer research: From hallmarks & biomarkers to tumor microenvironment progression